相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial
Dora Buonfrate et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
R. L. Gottlieb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
William A. Fischer et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Gilmar Reis et al.
LANCET GLOBAL HEALTH (2022)
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19 a randomised, placebo-controlled trial
Andrea Alemany et al.
LANCET RESPIRATORY MEDICINE (2022)
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019
Anca Streinu-Cercel et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
Anjum S. Kaka et al.
ANNALS OF INTERNAL MEDICINE (2022)
Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19
Olivier Pierre et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2022)
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Anil Gupta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg et al.
LANCET (2022)
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
D. J. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Effect of Early Treatment with Ivermectin among Patients with Covid-19
G. Reis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization A Systematic Review and Meta-analysis
Todd C. Lee et al.
JAMA NETWORK OPEN (2022)
Changes in Life Expectancy Between 2019 and 2020 in the US and 21 Peer Countries
Steven H. Woolf et al.
JAMA NETWORK OPEN (2022)
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Aekkachai Tuekprakhon et al.
CELL (2022)
Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
Prerna Arora et al.
LANCET INFECTIOUS DISEASES (2022)
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Qian Wang et al.
NATURE (2022)
Efficacy of single-dose and double-dose ivermectin early treatment in preventing progression to hospitalization in mild COVID-19: A multi-arm, parallel-group randomized, double-blind, placebo-controlled trial
Alireza Mirahmadizadeh et al.
RESPIROLOGY (2022)
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
Hugh Montgomery et al.
LANCET RESPIRATORY MEDICINE (2022)
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials
Mohammad Sadegh Rezai et al.
FRONTIERS IN MEDICINE (2022)
The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19-a double-blind, randomized placebo-controlled trial
Asaf Biber et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Ivermectin for preventing and treating COVID-19
Maria Popp et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
Jean-Francois Rossignol et al.
ECLINICALMEDICINE (2022)
Inhaled corticosteroids for the treatment of COVID-19
Mirko Griesel et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)
Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
Hyeonji Seo et al.
INFECTION AND CHEMOTHERAPY (2022)
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
Stefanie Reis et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)
Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews
Chantelle Garritty et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial
Patricia R. M. Rocco et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial
Eduardo Lopez-Medina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial
Nicole Ezer et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19 The TOGETHER Randomized Clinical Trial
Gilmar Reis et al.
JAMA NETWORK OPEN (2021)
The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2021)
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
Julio Vallejos et al.
BMC INFECTIOUS DISEASES (2021)
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection
Jin Yong Kim et al.
CLINICAL THERAPEUTICS (2021)
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection A Randomized Clinical Trial
Catherine E. Oldenburg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K. Korley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Primer on Bayesian Model-Averaged Meta-Analysis
Quentin F. Gronau et al.
ADVANCES IN METHODS AND PRACTICES IN PSYCHOLOGICAL SCIENCE (2021)
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Carlos Chaccour et al.
ECLINICALMEDICINE (2021)
Systemic corticosteroids for the treatment of COVID-19
Carina Wagner et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Antibiotics for the treatment of COVID-19
Maria Popp et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic
Isabelle Boutron et al.
ANNALS OF INTERNAL MEDICINE (2020)
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
Eric J. Lenze et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19
Ali S. Omrani et al.
ECLINICALMEDICINE (2020)
Bayesian Random-Effects Meta-Analysis Using the bayesmeta R Package
Christian Roever
JOURNAL OF STATISTICAL SOFTWARE (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The Bayesian New Statistics: Hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective
John K. Kruschke et al.
PSYCHONOMIC BULLETIN & REVIEW (2018)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)